Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-174344
Filing Date
2020-06-22
Accepted
2020-06-19 20:15:03
Documents
17
Period of Report
2020-07-22
Effectiveness Date
2020-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d933854ddef14a.htm DEF 14A 126635
2 GRAPHIC g933854dsp003.jpg GRAPHIC 3343
3 GRAPHIC g933854dsp019b.jpg GRAPHIC 15917
4 GRAPHIC g933854dsp019c.jpg GRAPHIC 1240
5 GRAPHIC g933854dsp019d.jpg GRAPHIC 2425
6 GRAPHIC g933854dsp019e.jpg GRAPHIC 1116
7 GRAPHIC g933854dsp019f.jpg GRAPHIC 1612
8 GRAPHIC g933854dsp019g.jpg GRAPHIC 1184
9 GRAPHIC g933854dsp019h.jpg GRAPHIC 11599
10 GRAPHIC g933854dsp019i.jpg GRAPHIC 18055
11 GRAPHIC g933854dsp020a.jpg GRAPHIC 10560
12 GRAPHIC g933854dsp020b.jpg GRAPHIC 5762
13 GRAPHIC g933854dsp020c.jpg GRAPHIC 863
14 GRAPHIC g933854dsp020d.jpg GRAPHIC 849
15 GRAPHIC g933854dsp19aa.jpg GRAPHIC 17170
16 GRAPHIC g933854g08m93.jpg GRAPHIC 5715
17 GRAPHIC g933854g14h12.jpg GRAPHIC 21930
  Complete submission text file 0001193125-20-174344.txt   294492
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-49908 | Film No.: 20976998
SIC: 2834 Pharmaceutical Preparations